In Situ Simulation Training in Transferring Critically Ill COVID-19 Patients

COVID-19 Respiratory Infection Clinical Trial

Official title:

In Situ Simulation Training for a Better Interprofessional Team Performance in Transferring Critically Ill COVID-19 Patients: A Prospective Randomized Control Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05113823
• Other study ID #: IndonesiaUAnes122
• Status: Completed
• Phase: N/A
• Start date: November 16, 2020
• Est. completion date: March 15, 2021

Study information

• Verified date: November 2021
• Source: Indonesia University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study aimed to determine the role of in situ simulation training during a pandemic by using standard and high-fidelity mannequins to improve interprofessional communication, skills, and teamwork in transferring critically ill COVID-19 patients.

Description:

Fourty subjects were randomly allocated into two large groups, the High Fidelity Simulator group and the Low Fidelity Simulator group. Each group was divided into small groups, consist of 2 doctors and 3 nurses. All subjects underwent the same interactive lectures, and two sessions of in-situ simulation according to their assign group. In-situ simulation and debriefing were performed by implementing appropriate personal protective equipment and social distancing. At the end of each simulation session, each group would underwent a debriefing session, which was performed by an experience instructor. The first simulation was aimed to teach participants skills and steps in transporting critically-ill COVID-19 patients according to the hospital check-list. While the second simulation was aimed to assess skills, team work and communication that participants had learned from the previous simulation, by using assessment tools that had been developed before. In addition to comparing each point in the assessment tool between the two groups, the points that had been earned were also added up to get the overall points for total skills, cooperation and communication score. At the end of the session, learner immediate feedback were also collected using an online feedback form, which provided accountability for attendance, content learning, and course evaluation feedback.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 40
• Est. completion date: March 15, 2021
• Est. primary completion date: November 19, 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 20 Years to 65 Years

Eligibility

Inclusion Criteria:

• in good physical condition
• had no history of involving in COVID-19 patients care
• willing to become study subject

Exclusion Criteria:

• doesn't want to become study subject

Related Conditions & MeSH terms

• COVID-19
• Respiratory Tract Infections
• Simulation of Physical Illness

Intervention

Procedure:
• Simulation Training
Simulation Training using High and Low Fidelity Simulator

Locations

Country	Name	City	State
Indonesia	Cipto Mangunkusumo Cental National Hospital	Jakarta	DKI Jakarta

Sponsors (1)

Lead Sponsor	Collaborator
Indonesia University

Country where clinical trial is conducted

Indonesia, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	rate of interprofessional communication	improvement of interprofessional communication in transferring critically ill COVID-19 patients	within 3 months
Primary	rate of skill	improvement of skill in transferring critically ill COVID-19 patients	within 3 months
Primary	rate of team work	improvement of team work in transferring critically ill COVID-19 patients	within 3 months